The Rise of Independent Clinical Trial Sites

When looking for the right trial site for their study, clinical sponsors need a number of specific measures and conditions that will ensure greatest value for them. Enrolling requirements must be met, but more importantly the most rigorous safety and quality...

2 months ago
Clinical Development,Clinical Operations,News

The Rise of Independent Clinical Trial Sites

When looking for the right trial site for their study, clinical sponsors need a number of specific measures and conditions that will ensure greatest value for them. Enrolling requirements must be met, but more importantly the most rigorous safety and quality...

2 months ago

The Medicinal Chemist Role in the World of AI

Over the last few decades, the field of medicinal chemistry has been significantly changed by major innovations such as the internet and, more recently, automation. These changes have all driven the area towards quicker and more cost-effective medicinal chemistry, focused...

2 months ago
R&D,AI & ML,Biology,News

The Medicinal Chemist Role in the World of AI

Over the last few decades, the field of medicinal chemistry has been significantly changed by major innovations such as the internet and, more recently, automation. These changes have all driven the area towards quicker and more cost-effective medicinal chemistry, focused...

2 months ago

The Challenges of CMC in Cell and Gene Therapies

Safety is one of the most important aspects of drug development. The need for a drug to be efficacious, consistent and non-harmful to humans is vital for its success. And where a treatment is new, highly variable, and can involve...

2 months ago
Bioprocess,CGT,Biomanufacturing,CMC,Regulatory Affairs,News

The Challenges of CMC in Cell and Gene Therapies

Safety is one of the most important aspects of drug development. The need for a drug to be efficacious, consistent and non-harmful to humans is vital for its success. And where a treatment is new, highly variable, and can involve...

2 months ago

Data Quality in Virtual Clinical Trials

Arguably no other area in pharmaceutical science has suffered under Covid-19 like clinical trials have. The damage done by Covid-19 - to patient engagement, to supply chains and to hospitals - has shaken the industry. But with such a crisis...

2 months ago
Clinical Development,Clinical Operations,News

Data Quality in Virtual Clinical Trials

Arguably no other area in pharmaceutical science has suffered under Covid-19 like clinical trials have. The damage done by Covid-19 - to patient engagement, to supply chains and to hospitals - has shaken the industry. But with such a crisis...

2 months ago

Will AI Transform R&D? An Interview with Laurent Audoly, Parthenon Therapeutics

The potential of AI and machine learning (ML) to transform almost every area of pharmaceuticals is profound. As we discovered recently in Proventa’s R&D White Paper, nowhere is this more evident than in research and development. Here, innovative technologies can...

3 months ago
R&D,AI & ML,News

Will AI Transform R&D? An Interview with Laurent Audoly, Parthenon Therapeutics

The potential of AI and machine learning (ML) to transform almost every area of pharmaceuticals is profound. As we discovered recently in Proventa’s R&D White Paper, nowhere is this more evident than in research and development. Here, innovative technologies can...

3 months ago

Continuing Clinical Trials under Covid-19

On 26 March 2020, Proventa International collaborated with ARENSIA on the first of a series of webinars looking at business continuity in the event of global pandemics. The webinar, which featured high levels of viewer engagement and a number of...

3 months ago
Clinical Development,Clinical Operations,News

Continuing Clinical Trials under Covid-19

On 26 March 2020, Proventa International collaborated with ARENSIA on the first of a series of webinars looking at business continuity in the event of global pandemics. The webinar, which featured high levels of viewer engagement and a number of...

3 months ago

How Close are We to a COVID-19 Treatment?

Despite the warnings of SARS, MERS, swine and bird flu, the coronavirus COVID-19 took the entire world by surprise. Governments, health workers and pharmaceutical executives were unprepared for the rapid spread of the pandemic across the globe. Now they are...

3 months ago
R&D,Clinical Development,Clinical Operations,News

How Close are We to a COVID-19 Treatment?

Despite the warnings of SARS, MERS, swine and bird flu, the coronavirus COVID-19 took the entire world by surprise. Governments, health workers and pharmaceutical executives were unprepared for the rapid spread of the pandemic across the globe. Now they are...

3 months ago

R&D: The Impact of AI in 2020

Whenever Proventa holds a Strategy Meeting around the world - regardless of meeting topic - the subject of AI comes up. It really is so important in pharma right now, with the potential to solve some of the sector's big...

4 months ago
Oncology,R&D,Bioinformatics,Biology,News

R&D: The Impact of AI in 2020

Whenever Proventa holds a Strategy Meeting around the world - regardless of meeting topic - the subject of AI comes up. It really is so important in pharma right now, with the potential to solve some of the sector's big...

4 months ago

What’s the Future of Patient Centricity?

Clinical trials rely fundamentally on patient engagement. While these trials can often prove life-saving, patient recruitment and retention has long been an issue for researchers. Simply increasing the amount of patients in a study means delays, increased costs, and patients...

5 months ago
Clinical Development,Clinical Operations,News

What’s the Future of Patient Centricity?

Clinical trials rely fundamentally on patient engagement. While these trials can often prove life-saving, patient recruitment and retention has long been an issue for researchers. Simply increasing the amount of patients in a study means delays, increased costs, and patients...

5 months ago

How to Select a CMO in Biomanufacturing

Experts often regard biomanufacturing efficiency as the most important part of global bioprocessing. But efficiency can be almost impossible as companies juggle hundreds of priorities across dozens of areas in the pipeline. Best practice can easily be subsumed by a...

5 months ago
Bioprocess,Biomanufacturing,News

How to Select a CMO in Biomanufacturing

Experts often regard biomanufacturing efficiency as the most important part of global bioprocessing. But efficiency can be almost impossible as companies juggle hundreds of priorities across dozens of areas in the pipeline. Best practice can easily be subsumed by a...

5 months ago